Tg Therapeutics TGTX Earnings Call Transcripts

NASDAQ TGTX
$65.76 +1.50 (+2.33%)
At close: Nov 11, 2026 · 4:00 PM EST
12 earnings calls on file for Tg Therapeutics, from Q4 2019 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Tg Therapeutics Q3 2026 Earnings Call

Nov 9, 2026 6,900 words · 30 min read
  • Jenna BoscoChief Communications Officer
  • Michael WeissChairman and Chief Executive Officer
  • Hari MiskinChief Development Officer
  • Adam WaldmanChief Commercial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Tg Therapeutics Earnings Call Transcripts

Calls12
LatestNov 9, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2025

Fiscal 2021

Fiscal 2020

Fiscal 2019

All 12 Tg Therapeutics transcripts Register to get access to Tg Therapeutics’s earnings call transcripts.